Sorry, there was a problem.

An unexpected error occurred and your request couldn't be handled. Please call a Dignity Health representative at
(844) 274-8497
OR
Chat with us here.

Reference code:

Insights & Innovations 2018 


Treatment of stroke has changed dramatically with advancements in technology and treatment modalities. The first minutes following the signs of stroke and subsequent care provided by EMS, Emergency Medicine, and Neuroscience team are critical to help decrease time to treatment. Every additional minute to treatment increases patient survival and decreases the likelihood of lasting disabilities.

A CME opportunity presented by Dignity Health Neurological Institute of Northern California.

Event Details 

November 8, 2018

5:30 p.m. to 8:30 p.m.

North Ridge Golf Club 
7600 Madison Ave. 
Fair Oaks, CA 95628


ONLINE REGISTRATION NOW OPEN BELOW. 


Our featured presentations include:

How the Stroke Stopwatch was Shattered
Gregory W. Albers, MD

The Role of First Responders in Acute Stroke Treatment in 2018     
Mark Ellis, Fire Chief

Intracranial Cerebral Artery Disease and the Role of Angioplasty and Stenting
Lucian Maidan, MD

Objectives:

At the conclusion of our program, participants should be able to implement the following changes to their professional practice:

  • Identify best practices in prehospital stroke triage, transport decision making, and collaborative actions to provide faster treatment times.
  • Apply new AHA guidelines to recognize which acute stroke patients are most appropriate for emergent mechanical thrombectomy. 
  • Identify patients that are candidates for intracranial angioplasty and stenting, and offer treatment before a second transient ischemic attack or cardiovascular accident.

Disclosures: 

As a provider accredited by the Institute for Medical Quality/California Medical Association, we must ensure balance, independence, objectivity and scientific rigor in all of our sponsored educational activities. We at Dignity Health Sacramento Office of Continuing Medical Education adhere to the ACCME Standards for Commercial Support.

The following speakers have indicated an affiliation with organizations which have interests related to the content of this program. Per Dignity Health Sacramento CME office policy, these potential conflicts of interest have been resolved. 

  • Dr. Maidan serves as PI for the for the following trials: ACTION II by Biogen, SMART by Penumbra, RAGE by Semmes Murphy, ARCADIA by NIH/NINDS, Roche, Bristol Meyers Squibb and Pfizer. All funds received support the Dignity Health Neurological Institute Research Program.
  • Dr. Albers receives equity from iSchemaView and fees as a consultant from iSchemaView and Medtronic 

The potential conflicts of interest have been resolved and determined the presentations are without bias.

  • Mark Ellis, Dignity Health Sacramento CME committee members, and all other planners involved and able to influence the content of this presentation have reported no relevant financial relationships/interest with any commercial entities that may have ties to this presentation.

This educational activity is supported in part by educational grants, and promotional exhibitors. 

Accreditation Statement:

Dignity Health Sacramento is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. 

Dignity Health Sacramento designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.